Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites

Aim. Improvement of refractory ascites (RA) outcomes in underlying cirrhotic portal hypertension (PH) through optimising the transjugular intrahepatic portosystemic shunting (TIPS) procedure among therapy measures.

Materials and methods. The survey included 107 patients with RA admitted to portal hypertension units of the Rostov State Medical University Surgical Clinic during 2007—2020. The patients were randomly assigned to two cohorts similar by gender, age, cirrhosis aetiology and condition severity. The control cohort had conventional paracentesis and albumin infusion. In cohort 2, 57 patients had minimally invasive endovascular TIPS surgery in a recommended setting.

Results. TIPS eliminated PH in all 57 patients of cohort 2. Cohort 1 was reported with progressive esophagogastric varices (EGV), their enlargement in 37 and rupture in 11 patients during the first 12 months. Cohort 2 revealed the grade 3—2 and 2—1 EGV reduction in 24 (41.1%) patients with shunt surgery and in 39 (68.4%) patients in one year. Esophagogastric variceal bleeding (EGVB) developed in 9 patients in cohort 1, with 7 lethal outcomes. No variceal bleeding was observed in cohort 2, with 7 patients having the portosystemic shunt dysfunction.

Conclusion. The TIPS procedure is justified in cirrhotic PH patients with RA for reducing the mortality rate in a one year follow-up.

1. Gadiyev S.I., Sariyeva K.G., Abdinov E.A. About Some Problems of Abdominal Surgery in Liver Cirrhosis. Annals of HPB Surgery. 2016;21(4):63-9 (In Russ.). DOI: 10.16931/1995-5464.2016463-69

2. Zakaryan, N.V., Pankov A.S., Shelesko A.A., Davtyan A.G., Malakhov E.B., Kirakosyan V.R. Our experience of endovascular interventions in portal hypertension. Endovascular surgery. 2018.5(4):420—4 (In Russ.).

3. Zubritsky V.F. Surgical treatment of portal hypertension. Medical Bulletin of the Ministry of internal Affairs. 2017;86(1):3—6 (In Russ.).

4. Ivanusa S.Ya., Onnitsev I.E., Khokhlov A.V., Yankovsky A.V. New endovideosurgical approaches in the treatment of portal hypertension syndrome. Health. Medical ecology. The science. 2017;176(3):46—52 (In Russ.). DOI: 10.5281/zenodo.842080

5. Mogilevets E.V., Vasilchuk L.F. Introduction of transjugular intrahepatic portosystem shunting. Journal of the Grodno state medical University. 2016;3(55): 152—6 (In Russ.).

6. Nazyrov F.G., Devyatov A.V., Babadzhanov A.K. Results and Prospects of Portosystemic Shunting in Patients with Liver Cirrhosis. Annals of HPB Surgery. 2015;20(2):31 — 9 (In Russ.) DOI: 10.16931/1995-5464.2015231-39

7. Nazyrov F.G., Devyatov A.V., Babadzhanov A.K., Dzhumaniyazov D.A., Baybekov R.R. The effectiveness of endoscopic interventions in liver cirrhosis patients. Annals of HPB Surgery. 2017;22(2):45—53 (In Russ.). DOI: 10.16931/19955464.2017245-53

8. Khoronko Yu.V., Kozyrevskiy M.A., Kosovtsev E.V., Kulikovskikh Ya.V. Modern possibilities of minimally invasive surgery in the treatment of portal hypertension of cirrhotic Genesis (clinical case). Modern problems of science and education. 2018;1:55 (In Russ.).

9. Efanov M.G., Bakulin I.G., Alikhanov R.B., Milekhina O.V. TIPS. When? To whom? What for? Gastroenterology. Special issue. 2014;3(52):78—91 (In Russ.).

10. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406—60. DOI: 10.1016/j.jhep.2018.03.024

11. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172-93. DOI: 10.1016/j.jhep.2018.06.0248.

12. Tripathi D., Stanley A.J., Hayes P.C., Travis S., Armstrong M.J., Tsochatzis E.A., et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut. 2020; 69:1173—92. DOI: 10.1136/gutjnl-2019-320221.